Ozzy Osbourne, Black Sabbath frontman, has died at the age of 76. He had suffered from numerous health problems and was ...

A new treatment for one type of Parkinson's disease may be on the horizon after researchers discovered a "brake" that can halt cell death. The study, led by researchers from Stanford University, ...

"TrailBio ® A9 Dopaminergic Neurons open new possibilities for Parkinson's research," said Dr. Jan Jensen, Chief Scientific Officer, Chief Technology Officer and founder of Trailhead Biosystems.

For decades, the narrative around Parkinson’s disease treatment has focused primarily on dopamine replacement. The loss of ...

A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson’s disease, according to results from a phase 1 ...

A treatment that could replenish cells in the brains of Parkinson’s disease patients caused no major negative reactions in two small, early-stage clinical trials. The research offers hope that ...

A once-a-week Parkinson’s injection could replace multiple daily pills, thanks to a new slow-release formulation developed by ...

Bemdaneprocel is the most clinically advanced investigational cell therapy in the U.S. for treating individuals living with Parkinson’s disease At 24 months, data from the Phase 1 exPDite trial ...

I’m upbeat about cell therapy development for Parkinson’s disease, but it has been a marathon. Now two new clinical trial papers published Wednesday in Nature on stem cell-based therapies for ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...